GHEMAXAN Solution for injection Ref.[49862] Active ingredients: Enoxaparin

Source: Health Products Regulatory Authority (IE)  Revision Year: 2022  Publisher: Chemi S.p.A., Via dei Lavoratori, 54, Cinisello Balsamo (MI), 20092 Italy

Product name and form

Ghemaxan 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringes.

Pharmaceutical Form

Solution for injection.

Clear, colourless to pale yellow solution.

Qualitative and quantitative composition

Each pre-filled syringe contains enoxaparin sodium 2,000 IU anti-Xa activity (equivalent to 20 mg) in 0.2 mL water for injections.

For the full list of excipients, see section 6.1.

Enoxaparin sodium is a biological substance obtained by alkaline depolymerisation of heparin benzyl ester derived from porcine intestinal mucosa.

Active Ingredient Description
Enoxaparin

Enoxaparin is a LMWH with a mean molecular weight of approximately 4,500 daltons, in which the antithrombotic and anticoagulant activities of standard heparin have been dissociated. The drug substance is the sodium salt and has a high anti-Xa activity.

List of Excipients

Water for injections

Pack sizes and marketing

Solution for injection in a 0.5 mL or 1 mL Type I glass pre-filled syringe with staked needle and needle guard (synthetic polyisoprene rubber) closed with elastomeric plunger stopper (chlorobutyl rubber) and plunger rod. The solution for injection is available in two different presentations:

1. The syringe is equipped with a needle guard

Ghemaxan 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringes: packs of 2, 6 or 10 pre-filled syringes and multipacks containing 12 (2 packs of 6), 20 (2 packs of 10), 24 (4 packs of 6), 30 (3 packs of 10), 50 (5 packs of 10) and 90 (9 packs of 10) pre-filled syringes.

2. The syringe is not equipped with a needle guard

Ghemaxan 2,000 IU (20 mg)/0.2 mL solution for injection in pre-filled syringes: packs of 2 and 10 pre-filled syringes.

Not all pack sizes may be marketed.

Marketing authorization holder

Chemi S.p.A., Via dei Lavoratori, 54, Cinisello Balsamo (MI), 20092
Italy

Marketing authorization dates and numbers

PA22937/001/001

Date of first authorisation: 19th June 2020

Drugs

Drug Countries
GHEMAXAN Austria, Brazil, Finland, Ireland

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.